We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$264B
AUM Growth
+$16.6B
Cap. Flow
-$3.28B
Cap. Flow %
-1.24%
Top 10 Hldgs %
18.75%
Holding
3,331
New
118
Increased
1,090
Reduced
1,840
Closed
95

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$474M
2
CELG
Celgene Corp
CELG
+$421M
3
AVGO icon
Broadcom
AVGO
+$411M
4
NFLX icon
Netflix
NFLX
+$387M
5
AAPL icon
Apple
AAPL
+$372M

Sector Composition

Rank Sector Weight
1 Technology 20.51%
2 Financials 14.64%
3 Healthcare 13.3%
4 Consumer Discretionary 10.29%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPNE
2801
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$714K ﹤0.01%
59,451
LAND
2802
Gladstone Land Corp
LAND
$360M
$712K ﹤0.01%
54,919
+7,802
+17% +$95.8K
CRNX icon
2803
Crinetics Pharmaceuticals
CRNX
$8.92B
$709K ﹤0.01%
28,241
-299
-1% -$5.69K
CBIO
2804
Crescent Biopharma
CBIO
$626M
$709K ﹤0.01%
1,340
RDI icon
2805
Reading International Class A
RDI
$34.3M
$709K ﹤0.01%
63,388
-466
-0.7% -$5.2K
BOCH
2806
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$709K ﹤0.01%
61,236
CLPR
2807
Clipper Realty
CLPR
$46.2M
$707K ﹤0.01%
66,677
+1,999
+3% +$19.1K
ELOX
2808
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$707K ﹤0.01%
2,401
-560
-19% -$113K
KALV
2809
DELISTED
KalVista Pharmaceuticals
KALV
$703K ﹤0.01%
39,479
+7,279
+23% +$95K
KVHI icon
2810
KVH Industries
KVHI
$157M
$703K ﹤0.01%
63,142
-91
-0.1% -$966
MCBS icon
2811
MetroCity Bankshares
MCBS
$1.03B
$703K ﹤0.01%
+40,171
New +$601K
UBX
2812
DELISTED
Unity Biotechnology
UBX
$703K ﹤0.01%
9,759
-84
-0.9% -$5.93K
FCBP
2813
DELISTED
First Choice Bancorp Common Stock
FCBP
$700K ﹤0.01%
25,972
PHR icon
2814
Phreesia
PHR
$773M
$699K ﹤0.01%
26,223
-26,592
-50% -$735K
BCBP icon
2815
BCB Bancorp
BCBP
$161M
$686K ﹤0.01%
49,709
-296
-0.6% -$3.93K
BGSF icon
2816
BGSF Inc
BGSF
$60M
$684K ﹤0.01%
31,264
-2,762
-8% -$56.2K
STEX
2817
Streamex Corp
STEX
$83M
$683K ﹤0.01%
11,532
SYRE icon
2818
Spyre Therapeutics
SYRE
$9.25B
$680K ﹤0.01%
3,558
-1,963
-36% -$385K
BWFG icon
2819
Bankwell Financial Group
BWFG
$533M
$676K ﹤0.01%
23,461
-146
-0.6% -$4.17K
AMR icon
2820
Alpha Metallurgical Resources
AMR
$1.93B
$674K ﹤0.01%
74,474
-1,236
-2% -$18.8K
DTF
2821
DTF Tax-Free Income 2028 Term Fund
DTF
$81.1M
$670K ﹤0.01%
45,249
NBN icon
2822
Northeast Bank
NBN
$1.14B
$670K ﹤0.01%
30,465
-217
-0.7% -$4.79K
STRS icon
2823
Stratus Properties
STRS
$154M
$670K ﹤0.01%
21,646
UUUU icon
2824
Energy Fuels
UUUU
$3.53B
$668K ﹤0.01%
349,693
RFL icon
2825
Rafael Holdings
RFL
$107M
$665K ﹤0.01%
37,803
+10,166
+37% +$185K

Similar funds

Nuveen's Q4 2019 Portfolio in Review

As of Q4 2019, Nuveen held 3,331 positions worth $264B, up 6.7% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Nuveen's Q4 2019 filing shows 118 new, 1,090 increased, 1,840 reduced and 95 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B. The largest sale was Cisco, an estimated $474M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q4 2019 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 8,077,161 shares worth $1.03B.
  • Nuveen added most to Bristol-Myers Squibb in Q4 2019, an estimated $649M increase.
  • Nuveen's biggest Q4 2019 reduction was Cisco, cutting an estimated $474M.
  • Nuveen fully exited Celgene Corp in Q4 2019, selling an estimated $421M.
  • Nuveen's ten largest holdings make up 19% of its $264B portfolio in Q4 2019.
  • Nuveen opened 118 new positions and closed 95 in Q4 2019.
  • Nuveen's portfolio value rose 6.7% quarter-over-quarter to $264B.

Based on Nuveen's 13F filing for Q4 2019, filed 14 Feb 2020.